Liver Disease in Mitochondrial Disorders

ABSTRACT

Liver involvement, a common feature in childhood mitochondrial hepatopathies, particularly in the neonatal period, may manifest as neonatal acute liver failure, hepatic steatohepatitis, cholestasis, or cirrhosis with chronic liver failure of insidious onset. There are usually significant neuromuscular symptoms, multisystem involvement, and lactic acidemia. The liver disease is usually progressive and eventually fatal. Current medical therapy of mitochondrial hepatopathies is largely ineffective, and the prognosis is usually poor. The role of liver transplantation in patients with liver failure remains poorly defined because of the systemic nature of the disease that does not respond to transplantation. Several specific molecular defects (mutations in nuclear genes such as SCO1, BCS1L, POLG, DGUOK, and MPV17 and deletion or rearrangement of mitochondrial DNA) have been identified in recent years. Prospective, longitudinal multicenter studies will be needed to address the gaps in our knowledge in these rare liver diseases.

KEYWORDS

Mitochondrial hepatopathies - genetics - pathogenesis

REFERENCES

• 1 Chinnery P F, DiMauro S. Mitochondrial hepatopathies.  J Hepatol. 2005;  43 207-209
• 2 Sokol R J, Treem W R. Mitochondria and childhood liver diseases.  J Pediatr Gastroenterol Nutr. 1999;  28 4-16
• 3 DiMauro S, Schon E A. Mitochondrial respiratory-chain diseases.  N Engl J Med. 2003;  348 2656-2668
• 4 Johns D R. Mitochondrial DNA and disease.  N Engl J Med. 1995;  333 638-644
• 5 Morris A A, Taanman J W, Blake J et al.. Liver failure associated with mitochondrial DNA depletion.  J Hepatol. 1998;  28 556-563
• 6 Labarthe F, Dobbelaere D, Devisme L et al.. Clinical, biochemical and morphological features of hepatocerebral syndrome with mitochondrial DNA depletion due to deoxyguanosine kinase deficiency.  J Hepatol. 2005;  43 333-341
• 7 Sutovsky P, Moreno R D, Ramalho-Santos J, Dominko T, Simerly C, Schatten G. Ubiquitin tag for sperm mitochondria.  Nature. 1999;  402 371-372
• 8 Sutovsky P, Van Leyen K, McCauley T, Day B N, Sutovsky M. Degradation of paternal mitochondria after fertilization: implications for heteroplasmy, assisted reproductive technologies and mtDNA inheritance.  Reprod Biomed Online. 2004;  8 24-33
• 9 Skladal D, Halliday J, Thornburn D R. Minimum birth prevalence of mitochondrial respiratory chain disorders in children.  Brain. 2003;  126 1905-1912
• 10 Darin N, Oldfors A, Moslemi A R, Holme E, Tulinius M. The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities.  Ann Neurol. 2001;  49 377-383
• 11 Cormier-Daire V, Chretien D, Rustin P et al.. Neonatal and delayed-onset liver involvement in disorders of oxidative phosphorylation.  J Pediatr. 1997;  130 817-822
• 12 Garcia-Cazorla A, De Lonlay P, Nassogne M C, Rustin P, Touati G, Saudubray J M. Long-term follow-up of neonatal mitochondrial cytopathies: a study of 57 patients.  Pediatrics. 2005;  116 1170-1177
• 13 Holve S, Hu D, Shub M, Tyson R W, Sokol R J. Liver disease in Navajo neuropathy.  J Pediatr. 1999;  135 482-493
• 14 Leonard J V, Shapiro A HV. Mitochondrial respiratory chain disorders. I: mitochondrial DNA defects.  Lancet. 2000;  355 299-304
• 15 Von Kleist-Retzow J C, Cormier-Daire V, Viot G et al.. Antenatal manifestations of mitochondrial respiratory chain deficiency.  J Pediatr. 2003;  143 208-212
• 16 Moraes C T, Shanske S, Tritschler H J et al.. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases.  Am J Hum Genet. 1991;  48 492-501
• 17 Bakker H D, Scholte H R, Dingemans K P, Spelbrink J N, Wijburg F A, Van der Bogert C. Depletion of mitochondrial deoxyribonucleic acid in a family with fatal neonatal liver disease.  J Pediatr. 1996;  128 683-687
• 18 Narkewicz M R, Sokol R J, Beckwith B, Sondheimer J, Silverman A. Liver involvement in Alpers disease.  J Pediatr. 1991;  119 260-267
• 19 Boyd S G, Harden A, Egger J, Pampiglione G. Progressive neuronal degeneration of childhood with liver disease (“Alpers' disease”): characteristic neurophysiological features.  Neuropediatrics. 1986;  17 75-80
• 20 Tzoulis C, Engelsen B A, Telstad W et al.. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases.  Brain. 2006;  129 1685-1692
• 21 Harding B N. Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome): a personal review.  J Child Neurol. 1990;  5 273-287
• 22 Egger J, Harding B N, Boyd S G, Wilson J, Erdohazi M. Progressive neuronal degeneration of childhood (PNDC) with liver disease.  Clin Pediatr (Phila). 1987;  26 167-173
• 23 Gauthier-Villars M, Landrieu P, Cormier-Daire V et al.. Respiratory chain deficiency in Alpers syndrome.  Neuropediatrics. 2001;  32 150-152
• 24 Pearson H A, Lobel J S, Kocoshis S A et al.. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction.  J Pediatr. 1979;  95 976-984
• 25 Morikawa Y, Matsuura N, Kakudo K, Higuchi R, Koike M, Kobayashi Y. Pearson's marrow/pancreas syndrome: a histological and genetic study.  Virchows Arch A Pathol Anat Histopathol. 1993;  423 227-231
• 26 Krahenbuhl S, Kleinle S, Henz S et al.. Microvesicular steatosis, hemosiderosis and rapid development of liver cirrhosis in a patient with Pearson's syndrome.  J Hepatol. 1999;  31 550-555
• 27 Majander A, Suomalainen A, Vettenranta K et al.. Congenital hypoplastic anemia, diabetes, and severe renal tubular dysfunction associated with a mitochondrial DNA deletion.  Pediatr Res. 1991;  30 327-330
• 28 Cormier-Daire V, Bonnefont J P, Rustin P et al.. Mitochondrial DNA rearrangement with onset as chronic diarrhea with villous atrophy.  J Pediatr. 1994;  124 63-70
• 29 Singleton R, Helgerson S D, Snyder R D et al.. Neuropathy in Navajo children: clinical and epidemiologic features.  Neurology. 1990;  40 363-367
• 30 Robinson B H. Lactic acidemia and mitochondrial disorders.  Mol Genet Metab. 2006;  89 3-13
• 31 Kreisberg R A. Glucose-lactate inter-relations in man.  N Engl J Med. 1972;  287 132-137
• 32 Rustin P, Chretien D, Bourgeron T et al.. Biochemical and molecular investigations in respiratory chain deficiencies.  Clin Chim Acta. 1994;  228 35-51
• 33 Holt I J, Harding A E, Morgan-Hughes J A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies.  Nature. 1988;  331 717-719
• 34 Cormier V, Rustin P, Bonnefont J P et al.. Hepatic failure in disorders of oxidative phosphorylation with neonatal onset.  J Pediatr. 1991;  119 951-954
• 35 Bohm M, Pronicka E, Karczmarewicz E et al.. Retrospective, multicentric study of 180 children with cytochrome c oxidase deficiency.  Pediatr Res. 2006;  59 21-26
• 36 Taanman J W. Human cytochrome c oxidase: structure, function, and deficiency.  J Bioenerg Biomembr. 1997;  29 151-163
• 37 Valnot I, Osmond S, Gigarel N et al.. Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy.  Am J Hum Genet. 2000;  67 1104-1109
• 38 Sacconi S, Salviati L, Sue C M et al.. Mutation screening in patients with isolated cytochrome c oxidase deficiency.  Pediatr Res. 2003;  53 224-230
• 39 De Lonlay P, Valnot I, Barrientos A et al.. A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure.  Nat Genet. 2001;  29 57-60
• 40 De Meirleir L, Seneca S, Damis E et al.. Clinical and diagnostic characteristics of complex III deficiency due to mutations in the BCS1L gene.  Am J Med Genet A. 2003;  121 126-131
• 41 Moraes C T, Shanske S, Tritschler H J et al.. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases.  Am J Hum Genet. 1991;  48 492-501
• 42 Jullig M, Eriksson S. Mitochondrial and submitochondrial localization of human deoxyguanosine kinase.  Eur J Biochem. 2000;  267 5466-5472
• 43 Wang L, Munch-Petersen B, Herrstrom Sjoberg A et al.. Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates.  FEBS Lett. 1999;  443 170-174
• 44 Mandel H, Szargel R, Labay V et al.. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA.  Nat Genet. 2001;  29 337-341
• 45 Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy.  Nat Genet. 2001;  29 342-344
• 46 Salviati L, Sacconi S, Mancuso M et al.. Mitochondrial DNA depletion and dGK gene mutations.  Ann Neurol. 2002;  52 311-317
• 47 Ferrari G, Lamantea E, Donati A et al.. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-γA.  Brain. 2005;  128 723-731
• 48 Horvath R, Hudson G, Ferrari G et al.. Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene.  Brain. 2006;  129 1674-1684
• 49 Spinazzola A, Viscomi C, Fernandez-Vizarra E et al.. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion.  Nat Genet. 2006;  38 570-575
• 50 Naviaux R K, Nguyen K V. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion.  Ann Neurol. 2004;  55 706-712
• 51 Nguyen K V, Sharief F S, Chan S SL, Copeland W C, Naviaux R K. Molecular diagnosis of Alpers syndrome.  J Hepatol. 2006;  45 108-116
• 52 Kaguni L S. DNA polymerase γ: the mitochondrial replicase.  Annu Rev Biochem. 2004;  73 293-320
• 53 Naviaux R K, Nyhan W L, Barshop B A et al.. Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers' syndrome.  Ann Neurol. 1999;  45 54-58
• 54 Lamantea E, Tiranti V, Bordoni A et al.. Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia.  Ann Neurol. 2002;  52 211-219
• 55 Vu T H, Tanji K, Holve S A et al.. Navajo neurohepatopathy: a mitochondrial DNA depletion syndrome?.  Hepatology. 2001;  34 116-120
• 56 Karadimas C L, Vu T H, Holve S A et al.. Navajo neurohepatopathy is caused by a mutation in the MPV17 gene.  Am J Hum Genet. 2006;  79 544-548
• 57 Rotig A, Cormier V, Blanche S et al.. Pearson's marrow-pancreas syndrome: a multisystem mitochondrial disorder in infancy.  J Clin Invest. 1990;  86 1601-1608
• 58 Sano T, Ban K, Ichiki T et al.. Molecular and genetic analyses of two patients with Pearson's marrow-pancreas syndrome.  Pediatr Res. 1993;  34 105-110
• 59 Jacobs LJAM, Jongbloed R JE, Wijburg F A et al.. Pearson syndrome and the role of deletion dimers and duplications in the mtDNA.  J Inherit Metab Dis. 2004;  27 47-55
• 60 MITOMAP .A Human Mitochondrial Genome Database. Atlanta, GA; Center for Molecular Medicine, Emory University http://Available at: www.mitomap.org Accessed October 24, 2006
• 61 Muraki K, Sakura N, Ueda H, Kihara H, Goto Y. Clinical implications of duplicated mtDNA in Pearson syndrome.  Am J Med Genet. 2001;  98 205-209
• 62 Gillis L A, Sokol R J. Gastrointestinal manifestations of mitochondrial disease.  Gastroenterol Clin North Am. 2003;  32 789-817
• 63 Chinnery P, Majamaa K, Turnbull D, Thorburn D. Treatment for mitochondrial disorders (review).  Cochrane Database Syst Rev. 2006;  (1) CD004426
• 64 Mahoney D J, Parise G, Tarnopolsky M A. Nutritional and exercise-based therapies in the treatment of mitochondrial disease.  Curr Opin Clin Nutr Metab Care. 2002;  5 619-629
• 65 Hart P E, Lodi R, Rajagopalan B et al.. Antioxidant treatment of patients with Freidreich ataxia: four year follow-up.  Arch Neurol. 2005;  62 621-626
• 66 Eleff S, Kennaway N G, Buist N R et al.. 31P NMR study of improvement in oxidative phosphorylation by vitamin K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle.  Proc Natl Acad Sci USA. 1984;  81 3529-3533
• 67 Chen R S, Huang C C, Chu N S. Coenzyme Q10 treatment in mitochondrial encephalomyopathies: short-term double-blind, crossover study.  Eur Neurol. 1997;  37 212-218
• 68 Muller W, Reimers C D, Berninger T et al.. Coenzyme Q10 in ophthalmoplegia plus: a double blind, cross over therapeutic trial.  J Neurol Sci. 1990;  98(suppl) 442
• 69 Frei B, Kim M C, Ames B N. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations.  Proc Natl Acad Sci USA. 1990;  87 4879-4883
• 70 Rodriguez M C, MacDonald J R, Mahoney D J, Parise G, Beal M F, Tarnopolsky M A. Beneficial effects of creatinine, CoQ(10), and lipoic acid in mitochondrial disorders.  Muscle Nerve. 2007;  35 235-242
• 71 Rustin P, Bonnet D, Rotiq A, Munnich A, Sidi D. Idebenone treatment in Freidreich patients: one-year-long randomized placebo-controlled trial.  Neurology. 2004;  62 524-525
• 72 Di Rocco M, Lamba L D, Minniti G, Caruso U, Naito E. Outcome of thiamine treatment in a child with Leigh disease due to thiamine-responsive pyruvate dehydrogenase deficiency.  Eur J Paediatr Neurol. 2000;  4 115-117
• 73 Bugiani M, Lamantea E, Invernizzi F et al.. Effects of riboflavin in children with complex II deficiency.  Brain Dev. 2006;  28 576-581
• 74 Stacpoole P W, Kerr D S, Barnes C et al.. Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children.  Pediatrics. 2006;  117 1519-1531
• 75 Oguro H, Iijima K, Takahashi K et al.. Successful treatment with succinate in a patient with MELAS.  Intern Med. 2004;  43 427-431
• 76 Schols L, Zange J, Abele M et al.. L-carnitine and creatine in Freidreich's ataxia: a randomized, placebo-controlled crossover trial.  J Neural Transm. 2005;  112 789-796
• 77 Kornblum C, Schroder R, Muller K et al.. Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study.  Eur J Neurol. 2005;  12 300-309
• 78 Mowat D, Kirby D M, Kamatu K R, Kan A, Thorburn D R, Christodoulou J. Respiratory chain complex III deficiency with pruritus, a novel vitamin responsive clinical feature.  J Pediatr. 1999;  134 352-354
• 79 Sokal E M, Sokol R, Cormier V et al.. Liver transplantation in mitochondrial respiratory chain disorders.  Eur J Pediatr. 1999;  158(suppl 2) S81-S84
• 80 Thomson M, McKiernan P, Buckels J, Mayer D, Kelly D A. Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplant in childhood.  J Pediatr Gastroenterol Nutr. 1998;  26 478-481
• 81 Dubern B, Broue P, Dubinsson C et al.. Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children.  Transplantation. 2001;  71 633-637
• 82 Delarue A, Paut O, Guys J-M et al.. Inappropriate liver transplantation in a child with Alpers-Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure.  Pediatr Transplant. 2000;  4 67-71
• 83 Cholestatic Liver Disease Consortium (CLiC) .Available at: http://rarediseasesnetwork.epi.usf.edu/clic/index.htm Accessed February 4, 2007